lactic acid has been researched along with gambogic acid in 5 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 5 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Chan, HF; Chen, M; He, C; Li, H; Li, Z; Liu, Y; Wang, S; Xu, Y | 1 |
Hu, J; Li, L; Li, R; Liu, B; Qian, H; Qian, X; Yang, M; Yu, L; Zhang, Z | 1 |
Arora, M; Ganugula, R; Guada, M; Kumar, MNVR; Saini, P | 1 |
Cao, J; Lu, Y; Shao, M; Wang, A; Wang, S; Wang, Y; Zhang, J; Zhong, Z | 1 |
Hua, D; Huang, J; Liu, B; Qian, H; Qian, X; Sha, H; Yu, L; Zhang, H; Zhang, Z | 1 |
5 other study(ies) available for lactic acid and gambogic acid
Article | Year |
---|---|
Triphenylphosphonium-modified poly(ethylene glycol)-poly(ε-caprolactone) micelles for mitochondria- targeted gambogic acid delivery.
Topics: A549 Cells; Antineoplastic Agents, Phytogenic; Apoptosis; Apoptosis Regulatory Proteins; Caspases; Cytochromes c; Drug Delivery Systems; Humans; Lactic Acid; Membrane Potential, Mitochondrial; Micelles; Mitochondria; Onium Compounds; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Trityl Compounds; Xanthones | 2017 |
Gambogic acid-loaded biomimetic nanoparticles in colorectal cancer treatment.
Topics: Animals; Antineoplastic Agents; Biocompatible Materials; Biomimetic Materials; Cell Death; Cell Line, Tumor; Colorectal Neoplasms; Erythrocyte Membrane; Humans; Lactic Acid; Male; Mice, Inbred BALB C; Nanoparticles; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Xanthones | 2017 |
Next Generation Precision-Polyesters Enabling Optimization of Ligand-Receptor Stoichiometry for Modular Drug Delivery.
Topics: Caco-2 Cells; Drug Carriers; Drug Delivery Systems; Humans; Lactic Acid; Ligands; Molecular Structure; Nanoparticles; Particle Size; Polyesters; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Receptors, Transferrin; Xanthones | 2017 |
Co-delivery of gambogic acid and TRAIL plasmid by hyaluronic acid grafted PEI-PLGA nanoparticles for the treatment of triple negative breast cancer.
Topics: Animals; Antineoplastic Agents; Cell Line, Tumor; Drug Carriers; Humans; Hyaluronan Receptors; Hyaluronic Acid; Lactic Acid; MCF-7 Cells; Mice; Nanoparticles; Plasmids; Polyethyleneimine; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; TNF-Related Apoptosis-Inducing Ligand; Triple Negative Breast Neoplasms; Xanthones | 2017 |
Anti-EGFR-iRGD recombinant protein modified biomimetic nanoparticles loaded with gambogic acid to enhance targeting and antitumor ability in colorectal cancer treatment.
Topics: Animals; Antineoplastic Agents; Apoptosis; Biomimetic Materials; Cell Line, Tumor; Cell Proliferation; Colorectal Neoplasms; Drug Carriers; ErbB Receptors; Humans; Lactic Acid; Lipids; Mice, Inbred BALB C; Mice, Nude; Nanoparticles; Oligopeptides; Polyglycolic Acid; Polylactic Acid-Polyglycolic Acid Copolymer; Recombinant Proteins; Xanthones | 2018 |